Atgen Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW787.5 |
Market Cap |
KRW381.7 B |
Shares Outstanding |
24.71 M |
Public Float |
20.47 M |
Address |
1st & 6th Floor, Health Care Park Seongnam-si GY 13605 Korea, Republic Of |
Employees | - |
Website | http://www.nkvue.com |
Updated | 09/14/2018 |
ATGen Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. Its products include NK cells under NK Vue brand, recombinant proteins, and monoclonal antibodies. The company was founded on January 14, 2002 and is headquartered at Seongnam-si, South Korea. |